Skip to main content
Caplight Logo









Wemedoo AG

Wemedoo AG

Private
SteinhausenHealthcare & Life Scienceshttps://wemedoo.com/

Last Round

Seed

Oct 8, 2024

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Wemedoo AG is a healthcare technology company that provides a unified clinical trial software platform intended to support faster, compliant, and more efficient clinical research operations.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Workflow Automation, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Freemium

AI Layer

Application

Keywords

unified clinical trial platformeClinical solutionsclinical trial managementdecentralized clinical trialsDCT platformEDCCTMSeTMFclinical trial AIePROrisk-based monitoringRTSMeConsentclinical data managementbiostatistics services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wemedoo AG Comparables

Compare Wemedoo AG with similar companies based on industry and business-model similarity.

Wemedoo AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Clinion
85%
Climedo Health
85%
nPhase, Inc.
84%

Wemedoo AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 8, 2024

Key People

Founding team and executive leadership

Nina Cihoric

Chief Executive Officer

Executive Team

Valérie Czaya

Chief Operating Officer

Executive Team

Wemedoo AG Investors

Notable investors and investment history

Wemedoo AG investors
InvestorRounds
DayOneSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 54% MoM, reaching 1.2K.

  • Jun 24, 2026

    Monthly visitors increased 719% MoM.

Wemedoo AG Filings

Explore SEC and related filing metadata, where available.

Wemedoo AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Wemedoo AG's valuation, stock price, and market status.

Is Wemedoo AG a public or private company?

Wemedoo AG is a private company.

What is the current stock price of Wemedoo AG?

Wemedoo AG is a private company with no public stock price. No recent secondary market data is available.

How much is Wemedoo AG worth (valuation)?

Valuation information for Wemedoo AG is not publicly available.

Can I buy Wemedoo AG stock?

Wemedoo AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Wemedoo AG's last funding round?

Funding round information for Wemedoo AG is not publicly available.

Who are the main investors in Wemedoo AG?

Investor information for Wemedoo AG is not publicly disclosed.

Will Wemedoo AG IPO soon?

No public IPO plans have been announced for Wemedoo AG.

How can I track Wemedoo AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Wemedoo AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSteinhausen
Employee Range35
Year Founded2020
Last FundingOct 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?